Jefferson Health

Physician Profile

Takami Sato, MD, PhD

Jefferson University Physician

Academic Title: Professor
Director, Metastatic Uveal Melanoma Program

Specialties
Medical Oncology
Medical Oncology - Uveal Melanoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
925 Chestnut Street
Suite 320A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340
Philadelphia
Bodine Center
111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 503-3158
Fax: (215) 955-9600

Medical Services

Board Certifications

  • Pediatrics

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Best Doctors in America 2011,2010,2009,2008,2007,2006,2005

America's Top Oncologists 2007

Notes

Dr. Sato also specializes in Cancer Immunotherapy.

Education

  • Jichi Medical University, Japan, Medical School

Residency

  • Oita Prefectural Hospital, Japan

Fellowship

  • Jichi Medical University, Japan

Recent Publications

Immune check point inhibitors combination in melanoma: Worth the toxicity?

Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization

Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma

Biology of advanced uveal melanoma and next steps for clinical therapeutics

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases

Biology of advanced uveal melanoma and next steps for clinical therapeutics

Treatment strategies for clinically detectable metastatic uveal melanoma

Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth

Tumor necrosis factor-α blockade and development of uveal melanoma: Expected adverse effect or just coincidence?

Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity

Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes

High-dose vincristine sulfate liposome injection (Marqibo) is not associated with clinically meaningful hematologic toxicity

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial

The potential role of sunitinib targeting melanomas

Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma

A pilot study of sunitinib malate in patients with metastatic uveal melanoma

Uveal melanoma trapped in the temple of doom

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma